logo
Share SHARE
FONT-SIZE Plus   Neg

Watson Says It Confirms Glumetza Patent Challenge - Quick Facts

Watson Pharmaceuticals, Inc. (WPI) confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application, or ANDA, with the U.S. Food and Drug Administration, or FDA, seeking approval to market Metformin Hydrochloride Extended-release Tablets USP, 1000 mg.

Watson's Metformin Hydrochloride Extended-release Tablets are a generic version of Depomed, Inc.'s Glumetza. Glumetza is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Discount retailer Five Below Inc (FIVE), Wednesday said its first-quarter profit increased from a year ago, driven largely by a 22 percent jump in sales, with both earnings and revenues coming in ahead of Wall Street estimates. Five Below detailed a strong outlook for the second quarter and lifted... Yahoo Inc has won exclusive rights to the National Football League's first Internet-only broadcast of a football game between the Buffalo Bills and Jacksonville Jaguars that will be played in London on Sunday, October 25. Applications for home mortgages in the U.S. declined last week on a seasonally adjusted basis as purchase and refinancing applications waned, shows data by the Mortgage Bankers Association.
comments powered by Disqus
Follow RTT